[{"id":"e55df251-1fde-47bd-86f1-be2ff4bd4e5a","acronym":"VISTA","url":"https://clinicaltrials.gov/study/NCT03740256","created_at":"2021-01-18T18:19:18.650Z","updated_at":"2025-02-25T16:31:39.867Z","phase":"Phase 1","brief_title":"Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors","source_id_and_acronym":"NCT03740256 - VISTA","lead_sponsor":"Baylor College of Medicine","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TT16"],"overall_status":"Recruiting","enrollment":" Enrollment 45","initiation":"Initiation: 12/14/2020","start_date":" 12/14/2020","primary_txt":" Primary completion: 12/30/2025","primary_completion_date":" 12/30/2025","study_txt":" Completion: 12/30/2038","study_completion_date":" 12/30/2038","last_update_posted":"2025-02-07"}]